TALS · Categories · Form 4

TALS - SEC Form 4 insider transactions

Talaris Therapeutics Inc. (TALS) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for TALS

• 906d
  SEC Form 4 filed by Siegall Clay B

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 959d
  Thiara Parvinder was granted 75,782 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 959d
  Srivastava Sapna was granted 518 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 959d
  SEC Form 4 filed by Robinson Ryan F.

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 959d
  Middlekauff W Bradford was granted 69,201 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 959d
  Mcdade Mark was granted 348,949 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 959d
  Kulkarni Sandeep Chidambar was granted 716,085 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 959d
  Kantoff Aaron was granted 37,891 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 959d
  Jones Susan Dana was granted 22,934 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 959d
  Johnson Kevin Bruce was granted 57,834 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 959d
  Chyung Yung H. was granted 56,836 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 959d
  Castelein Caley was granted 954,558 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 1068d
  SEC Form 4 filed by Fenton Mary Kay

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1068d
  SEC Form 4 filed by Requadt Scott

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1090d
  SEC Form 4 filed by Srivastava Sapna

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1090d
  SEC Form 4 filed by Smith Karen L.

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1090d
  SEC Form 4 filed by Shah Gaurav

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1090d
  SEC Form 4 filed by Nader Francois

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1090d
  SEC Form 4 filed by Mcdade Mark

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1090d
  SEC Form 4 filed by Mackay Geoffrey

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1090d
  SEC Form 4 filed by Ildstad Suzanne

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1090d
  SEC Form 4 filed by Agarwala Sandip

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1095d
  SEC Form 4 filed by Ildstad Suzanne

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1097d
  SEC Form 4 filed by Ildstad Suzanne

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1099d
  SEC Form 4 filed by Ildstad Suzanne

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1140d
  SEC Form 4 filed by Ildstad Suzanne

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1144d
  SEC Form 4 filed by Ildstad Suzanne

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1146d
  SEC Form 4 filed by Ildstad Suzanne

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1158d
  SEC Form 4 filed by Ildstad Suzanne (Amendment)

  4/A - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1158d
  SEC Form 4 filed by Ildstad Suzanne (Amendment)

  4/A - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1158d
  SEC Form 4 filed by Ildstad Suzanne (Amendment)

  4/A - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1158d
  SEC Form 4 filed by Ildstad Suzanne (Amendment)

  4/A - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1158d
  SEC Form 4 filed by Ildstad Suzanne (Amendment)

  4/A - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1176d
  SEC Form 4 filed by Talaris Therapeutics Inc.

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1189d
  SEC Form 4: Ildstad Suzanne sold $13,992 worth of shares (6,806 units at $2.06), decreasing direct ownership by 0.22% to 3,064,560 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1194d
  SEC Form 4: Ildstad Suzanne sold $59 worth of shares (29 units at $2.05), decreasing direct ownership by 0.00% to 3,071,366 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1201d
  SEC Form 4: Ildstad Suzanne sold $7,185 worth of shares (3,500 units at $2.05), decreasing direct ownership by 0.11% to 3,071,395 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1203d
  SEC Form 4: Ildstad Suzanne sold $13,446 worth of shares (6,551 units at $2.05), decreasing direct ownership by 0.21% to 3,074,895 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1221d
  SEC Form 4 filed by Zdanowski Michael

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1221d
  SEC Form 4: Requadt Scott was granted 4 shares, increasing direct ownership by 0.00% to 590,193 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1221d
  SEC Form 4 filed by Krieger Nancy

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1221d
  SEC Form 4 filed by Fenton Mary Kay

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1364d
  SEC Form 4: Zdanowski Michael was granted 120,000 shares, increasing direct ownership by 8,163% to 121,470 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1364d
  SEC Form 4: Requadt Scott was granted 80,000 shares, increasing direct ownership by 16% to 590,189 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1364d
  SEC Form 4: Krieger Nancy was granted 80,000 shares, increasing direct ownership by 32% to 330,233 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1364d
  SEC Form 4: Fenton Mary Kay was granted 80,000 shares, increasing direct ownership by 8,000% to 81,000 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1364d
  SEC Form 4: Nader Francois disposed of 386,932 shares, acquired 386,932 shares and bought $500,020 worth of shares (138,500 units at $3.61) (Amendment)

  4/A - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1385d
  SEC Form 4: Ildstad Suzanne sold $1,470,000 worth of shares (525,000 units at $2.80), decreasing direct ownership by 15% to 3,081,446 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1406d
  SEC Form 4: Requadt Scott bought $167,374 worth of shares (39,382 units at $4.25), increasing direct ownership by 8% to 508,680 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1411d
  SEC Form 4: Requadt Scott bought $36,571 worth of shares (8,618 units at $4.24), increasing direct ownership by 2% to 469,298 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1413d
  SEC Form 4: Requadt Scott bought $35,412 worth of shares (9,444 units at $3.75), increasing direct ownership by 2% to 460,680 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1456d
  SEC Form 4 filed by Mcdade Mark

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1456d
  SEC Form 4 filed by Shah Gaurav

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1456d
  SEC Form 4 filed by Smith Karen L.

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1456d
  SEC Form 4 filed by Mackay Geoffrey

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1456d
  SEC Form 4 filed by Nader Francois

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1456d
  SEC Form 4 filed by Agarwala Sandip

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1456d
  SEC Form 4 filed by Srivastava Sapna

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1483d
  SEC Form 4 filed by Smith Karen L.

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1587d
  SEC Form 4: Ildstad Suzanne received a gift of 1,200,000 shares and gifted 1,200,000 shares, decreasing direct ownership by 25% to 3,606,446 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)

Other TALS categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends